Robbinsville, NJ, June 30, 2017—DCAT Sharp Sourcing, held June 27, 2017 at the Hyatt Regency Hotel in New Brunswick, New Jersey, brought together pharmaceutical company executives and suppliers to examine issues of topical importance impacting the pharmaceutical manufacturing value chain and the customer–supplier relationship.
Sharp Sourcing kicked off with two specialized forums, respectively for buyers and suppliers. The Buyers’ Forum, an interactive session for sourcing, procurement, and supply management professionals, addressed three topics: (1) talent in sourcing and procurement with a focus on Millennials and Generation Y professionals; (2) collaborative supply-chain planning; and (3) technology-led sourcing of contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs).
The Suppliers Forum, held concurrently to the Buyers’ Forum, featured pharmaceutical customer-centric insights for suppliers, CDMOs, and CMO. Daniel Cohen, Managing Director, RBC Capital Markets LLC, provided a Wall Street perspective on the pharmaceutical outsourcing market for CMDOs and CMOs.
The Suppliers’ Forum also examined specific segments in pharmaceutical outsourcing. Valdas Jurkauskas, PhD, Senior Director, Pharmaceutical Development and Manufacturing, Corbus Pharmaceuticals, provided insight on the push–pull interaction between regulators and sponsor companies in defining starting materials, the beginning point for a cGMP manufacturing process. Michael Semo, Advisor, External R&D Strategy, Small Molecule, Eli Lilly and Company, shared the company’s experience in early-stage development for small-molecule APIs, and Sean M. Johnston, Former Vice President, Manufacturing, Paratek Pharmaceuticals, provided case examples of managing both API and drug product development and manufacturing in the customer–supplier relationship.
Buyers and suppliers came together for the Joint Afternoon Session to learn from leading executives on practical ways to resolve common challenges in sourcing and procurement and on new tools for managing the customer–supplier relationship. This session featured a roundtable of chief procurement officers (CPOs), a discussion of supply-chain financing, and a market outlook for APIs.
The afternoon session concluded with an engaging and uplifting keynote address by former NY Giants quarterback and Super Bowl MVP Phil Simms. Mr. Simms recounted leading his team through ups and downs during his NFL career and the key lessons learned in driving his and his team’s success . Attendees enjoyed a question and answer session with Mr. Simms and joined him for a meet and greet during the final networking reception.
As a not-for-profit, member-supported business development association for the global pharmaceutical manufacturing industry, the Drug, Chemical & Associated Technologies Association (DCAT) is committed to providing programs, events and services that help our members expand their network of customers, suppliers and colleagues in the industry. Founded in 1890, DCAT is the industry’s premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries. With over 450 corporate members, DCAT is headquartered in Robbinsville, New Jersey.
Senior Communications & Technology Specialist
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.